FIELD: biochemistry, medicine.
SUBSTANCE: invention relates to phenylalanine derivatives of formula I , wherein X1 and X2 are halogen; Q is CH2 or -(CH2)-; Y is C1-C6-alkyl; CO2R is carboxylic group which may be transetherified; or pharmaceutically acceptable salts thereof. Pharmaceutical composition is disclosed having inhibition activity against α4-integrine mediated cell adhesion. Said composition includes therapeutically effective amount of claimed derivative or pharmaceutically acceptable salt thereof in mixture with pharmaceutically acceptable carrier or diluent. Derivatives of present invention or pharmaceutically acceptable salt thereof are useful as active therapeutic agent inhibiting α4-integrine mediated cell adhesion. Also disclosed are application of phenylalanine derivatives of formula I or pharmaceutically acceptable salts thereof to produce drug for treatment of diseases associated with α4-integrine mediated cell adhesion. Method for treatment or prophylaxis diseases associated with α4-integrine mediated cell adhesion includes administrating to patient effective amount of phenylalanine derivatives of formula I or pharmaceutically acceptable salt thereof. Further methods (variants) for production of target derivatives are disclosed.
EFFECT: α4-integrine inhibiting phenylalanine derivatives.
20 cl, 42 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PREPARING PHENYLALANINE DERIVATIVES AND THEIR SEMI-FINISHED PRODUCTS | 2003 |
|
RU2280641C2 |
SULFONAMIDE DERIVATIVE AND MEDICINAL USE THEREOF | 2013 |
|
RU2607081C2 |
NOVEL PHENYLALANINE DERIVATIVES | 2004 |
|
RU2390520C2 |
APPLICATION OF REMYELINATING MEDICATION FOR STIMULATION OF NERVE CELLS IN CASE OF DEMYELINATING DISEASE | 2004 |
|
RU2412721C2 |
NOVEL DERIVATIVES OF PHENYLALANINE | 2004 |
|
RU2311405C1 |
TERT-BUTYL-N-[2-{4-[6-AMINO-5-(2,4-DIFLUOROBENZOYL)-2-OXOPYRIDIN-1(2H)-YL]-3,5-DIFLUOROPHENYL}ETHYL]-L-ALANINATE OR SALT, HYDRATE OR SOLVATE THEREOF | 2013 |
|
RU2676329C2 |
AROMATIC 6,7-DISUBSTITUTED 3-QUINOLINECARBOXAMIDE DERIVATIVES, METHOD FOR PRODUCTION THEREOF (VARIANTS), PHARMACEUTICAL COMPOSITION CONTAINING THE SAME AND USE THEREOF IN DRUG MANUFACTURING | 2002 |
|
RU2281940C2 |
A CONJUGATE CONTAINING A NEUROTENSIN RECEPTOR LIGAND AND ITS APPLICATION | 2015 |
|
RU2743781C2 |
NOVEL HELIOMYCIN DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS THEREOF INHIBITING TUMOR GROWTH | 2018 |
|
RU2670763C1 |
NOVEL CLASS OF SELECTIVE AGONISTS OF SOMATOSTATIN RECEPTORS | 2014 |
|
RU2603962C2 |
Authors
Dates
2005-04-27—Published
2001-08-27—Filed